Skip to main content
Premium Trial:

Request an Annual Quote

Next-Gen Sequencing in the Clinic

A post at MassGenomics summarizes a lecture that the Mayo Clinic's David Smith gave on how the institution is using next-gen sequencing in clinical application. For the most part, Mayo is using it for rare variant detection in tumors, detecting mutations in mitochondrial DNA, and transcriptional profiling.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.